becton dickinson and co
(BDX:New York Consolidated)
Transactions by BECTON DICKINSON AND CO (BDX) in the last 6 months
Becton, Dickinson and Company (NYSE:BDX) acquired GenCell Biosystems Ltd. from Kieran Curran for $150 million on October 13, 2014. Jefferies LLC acted as a financial advisor to GenCell Biosystems Ltd. Donal O’Connell of Pegasus Capital acted as the financial advisor for GenCell.
Becton, Dickinson and Company (NYSE:BDX) entered into an agreement and plan of merger to acquire CareFusion Corporation (NYSE:CFN) from The Vanguard Group, Inc. and others for $11.8 billion in cash and stock on October 5, 2014.Under the terms, CareFusion shareholders will receive $49 in cash and 0.0777 of a share of Becton, Dickinson for each share of CareFusion. Upon closing, Becton, Dickinson shareholders will own approximately 92% of the combined company and CareFusion ...
Perella Weinberg Partners LP
|Astellas Pharma Inc||¥1,767 JPY||-17.00|
|Boston Scientific Corp||$14.94 USD||+0.095|
|Ecolab Inc||$106.97 USD||+1.09|
|Illumina Inc||$200.24 USD||+3.08|
|Zimmer Holdings Inc||$117.01 USD||+0.025|
|View Industry Companies|